vs
Side-by-side financial comparison of Curbline Properties Corp. (CURB) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $54.1M, roughly 1.3× Curbline Properties Corp.). Curbline Properties Corp. runs the higher net margin — 17.6% vs -49.0%, a 66.7% gap on every dollar of revenue.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
CURB vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $54.1M | $70.6M |
| Net Profit | $9.6M | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | 17.8% | -56.7% |
| Net Margin | 17.6% | -49.0% |
| Revenue YoY | — | 81958.1% |
| Net Profit YoY | — | 54.9% |
| EPS (diluted) | $0.08 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $54.1M | — | ||
| Q3 25 | $48.6M | $70.6M | ||
| Q2 25 | $41.4M | — | ||
| Q1 25 | $38.7M | — | ||
| Q3 24 | $29.8M | — |
| Q4 25 | $9.6M | — | ||
| Q3 25 | $9.4M | $-34.6M | ||
| Q2 25 | $10.4M | — | ||
| Q1 25 | $10.6M | — | ||
| Q3 24 | $-15.4M | — |
| Q4 25 | 17.8% | — | ||
| Q3 25 | 19.3% | -56.7% | ||
| Q2 25 | 25.3% | — | ||
| Q1 25 | 27.6% | — | ||
| Q3 24 | -51.8% | — |
| Q4 25 | 17.6% | — | ||
| Q3 25 | 19.2% | -49.0% | ||
| Q2 25 | 25.1% | — | ||
| Q1 25 | 27.3% | — | ||
| Q3 24 | -51.8% | — |
| Q4 25 | $0.08 | — | ||
| Q3 25 | $0.09 | — | ||
| Q2 25 | $0.10 | — | ||
| Q1 25 | $0.10 | — | ||
| Q3 24 | $-0.15 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $289.6M | $490.9M |
| Total DebtLower is stronger | $423.2M | — |
| Stockholders' EquityBook value | $1.9B | $503.0M |
| Total Assets | $2.5B | $577.1M |
| Debt / EquityLower = less leverage | 0.22× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $289.6M | — | ||
| Q3 25 | $430.1M | $490.9M | ||
| Q2 25 | $429.9M | — | ||
| Q1 25 | $594.0M | — | ||
| Q3 24 | $2.5M | — |
| Q4 25 | $423.2M | — | ||
| Q3 25 | $396.4M | — | ||
| Q2 25 | $99.1M | — | ||
| Q1 25 | $99.0M | — | ||
| Q3 24 | — | — |
| Q4 25 | $1.9B | — | ||
| Q3 25 | $1.9B | $503.0M | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $1.9B | — | ||
| Q3 24 | $1.1B | — |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.4B | $577.1M | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.1B | — | ||
| Q3 24 | $1.2B | — |
| Q4 25 | 0.22× | — | ||
| Q3 25 | 0.21× | — | ||
| Q2 25 | 0.05× | — | ||
| Q1 25 | 0.05× | — | ||
| Q3 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $124.6M | $-84.6M |
| Free Cash FlowOCF − Capex | — | $-84.7M |
| FCF MarginFCF / Revenue | — | -120.1% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | 13.04× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $124.6M | — | ||
| Q3 25 | $39.2M | $-84.6M | ||
| Q2 25 | $34.2M | — | ||
| Q1 25 | $25.4M | — | ||
| Q3 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $-84.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -120.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
| Q4 25 | 13.04× | — | ||
| Q3 25 | 4.19× | — | ||
| Q2 25 | 3.28× | — | ||
| Q1 25 | 2.40× | — | ||
| Q3 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
